Aerobic exercise promotes PDAC vascular normalization through S1PR1 signaling in tumor endothelial cells

Riccardo Ballarò,Sumedha Pareek,Jonghae Lee,Hetal Patel,Priya Tirumala,Guanshu Liu,Karma Hayek,Hannah Savage,Bella Guerrouahen,An Ngo-Huang,Nathan Parker,Matthew HG Katz,Maria Petzel,Florencia McAllister,Robin Wright,Lin Tan,Philip L Lorenzi,Keri Schadler

DOI: https://doi.org/10.1101/2024.02.14.580332

2024-02-22

Abstract:Pancreatic Ductal Adenocarcinoma (PDAC) is characterized by high resistance to anti-cancer therapies. This resistance is caused in part by hypo-vascularization and dysfunctional vessels which inefficiently deliver chemotherapy. Here, we define the mechanism of aerobic exercise-induced tumor vascular remodeling and improved chemotherapy delivery and efficacy. We found that aerobic exercise was able to improve tumor vascular function and increase the number of lymphatic vessels, and these effects were associated with increased gemcitabine delivery to and efficacy against PDAC in mice. Further, exercise increased sphingosine-1-phosphate (S1P) in plasma and the activation of sphingosine-1-phosphate receptor 1 (S1PR1) in tumor endothelial cells. S1PR1 endothelial cell-specific deletion blunted the exercise-induced improvements in tumor vascular function, gemcitabine efficacy and drug concentration. Preclinical findings were validated in a patient cohort in which we found that exercise during neoadjuvant chemotherapy remodeled PDAC vasculature and improved tumor vascular function. These findings provide direct evidence that exercise increases chemotherapy delivery and efficacy by improving vascular function, defining S1PR1 as a necessary mediator of exercise-induced vascular remodeling.

Cancer Biology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the resistance of pancreatic ductal adenocarcinoma (PDAC) to chemotherapeutic drugs. One of the remarkable features of PDAC is poor angiogenesis and dysfunction, which leads to the ineffective delivery of chemotherapeutic drugs to the tumor site, thereby reducing the treatment effect. By studying how aerobic exercise promotes the vascular normalization of PDAC and whether this normalization can improve the delivery and efficacy of chemotherapeutic drugs, the paper explores new strategies to improve the chemotherapeutic effect of PDAC.

Specifically, the researchers found that aerobic exercise can improve the vascular function of PDAC and increase the number of lymphatic vessels, and these effects are related to the increased delivery and efficacy of the chemotherapeutic drug gemcitabine in mice. Further research shows that exercise increases the level of sphingosine - 1 - phosphate (S1P) in plasma and activates sphingosine - 1 - phosphate receptor 1 (S1PR1) in tumor endothelial cells. By specifically deleting S1PR1, the researchers verified the crucial role of S1PR1 in exercise - induced improvement of tumor vascular function, increased gemcitabine efficacy and drug concentration.

In addition, the researchers also verified these pre - clinical findings in a group of patients. The results show that exercise during neoadjuvant chemotherapy can reshape the vascular structure of PDAC and improve the vascular function of the tumor. These findings provide direct evidence that exercise increases the delivery and efficacy of chemotherapeutic drugs by improving vascular function and identify S1PR1 as a necessary mediator for exercise - induced vascular remodeling.